David van Duin, MD, PhD

Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States

David van Duin, MD, PhD, FIDSA, FAST. Professor in the Infectious Diseases Division at the University of North Carolina. Dr. van Duin is the founding Director of the Immunocompromised Host ID service. His main research interests are infections caused by multi-drug resistant Gram-negative bacteria, especially carbapenem-resistant Enterobacterales, and infections in immunocompromised patients.

Disclosure(s): AbbVie Inc: Advisor/Consultant; Merck & Co., Inc.: Advisor/Consultant, Grant/Research Support; Parexel International: DSMB; Pfizer, Inc.: Advisor/Consultant, Honoraria; Roche Pharmaceuticals: Advisor/Consultant; TEVA: Advisor/Consultant

Presentation(s):

• 15 - New Antimicrobials in the Pipeline

  Monday, October 20, 2025
  8:00 AM - 9:00 AM US ET

• 25 - Blood and Guts: Microbiome Discoveries

  Monday, October 20, 2025
  10:30 AM - 11:45 AM US ET

• 78 - Aerobactin Gene iuc as a Virulence Marker Associated with Increased Mortality in Carbapenem-Resistant Klebsiella pneumoniae infections: A Multicenter Observational Cohort Study from China

  Monday, October 20, 2025
  11:18 AM - 11:30 AM US ET

• 556 - Using a novel Anaerobic Activity Index to assess risk for poor outcomes in burn patients in a burn intensive care unit

  Wednesday, October 22, 2025
  10:45 AM - 11:00 AM US ET